Drug
Ciltistotug clinical trials
Also written YH003.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How studies write it
Studies that test it under each name
Development codes
- YH003
- 5
Studies by the year they started
5 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Eucure (Beijing) Biopharma Co., Ltd (5)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ciltistotug is read from its arms, and is right about nine times in ten. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with CancersCompletedPhase 2Eucure (Beijing) Biopharma Co., LtdNCT05031494Written as YH003
- A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal MelanomaCompletedPhase 2Eucure (Beijing) Biopharma Co., LtdNCT05420324Written as YH003
- A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid TumorsCompletedPhase 1Eucure (Beijing) Biopharma Co., LtdNCT05176509Written as YH003
- A Study to Evaluate YH003 in Subjects With Advanced Solid TumorsCompletedPhase 1Eucure (Beijing) Biopharma Co., LtdNCT05017623Written as YH003
- A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid TumorsCompletedPhase 1/2Eucure (Beijing) Biopharma Co., LtdNCT04481009Written as YH003
Codes
What other systems call ciltistotug · ClinicalTrials.gg INT016619
- UNII (FDA) G2CB897733CILTISTOTUGOne source FDA
- NCI Thesaurus C178347CiltistotugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | G2CB897733 | CILTISTOTUG | One source FDA |
| NCI Thesaurus | C178347 | Ciltistotug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.